`Filed: October 28, 2015
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`________________
`
`RANBAXY INC.
`Petitioner,
`
`v.
`
`JAZZ PHARMACEUTICALS, INC. and
`JAZZ PHARMACEUTICALS IRELAND LTD.
`Patent Owner
`
`________________
`
`Case IPR2016-00024
`Patent 8,772,306
`________________
`
`
`
`PATENT OWNER MANDATORY NOTICES UNDER
`35 U.S.C. §§ 311-319 AND 37 C.F.R. §§ 42.8, 42.100 ET. SEQ.
`
`03387-00001/7349405.1
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case IPR2016-00024
` Patent 8,772,306
`
`
`Patent Owner Mandatory Notices
`
`
`REAL PARTIES-IN-INTEREST
`
`Pursuant to the requirements of 37 C.F.R. § 42.8(b)(1), the undersigned state
`
`that Jazz Pharmaceuticals, Inc. (“Jazz”) and Jazz Pharmaceuticals Ireland Ltd.
`
`(“Jazz Ireland”) are the real parties-in-interest. Jazz is a corporation organized and
`
`existing under the laws of the State of Delaware, having a principal place of
`
`business at 3180 Porter Drive, Palo Alto, California 94304. Jazz Ireland is a
`
`corporation existing under the laws of Ireland, having a principle place of business
`
`at One Burlington Road, Fourth Floor, Connaught House, Dublin, Ireland 4. Jazz
`
`Ireland owns by assignment the entire right, title, and interest in U.S. Patent No.
`
`8,772,306 (the “’306 patent”) by virtue of an Assignment of rights from the
`
`inventor, Mark Eller, to Jazz (Reel/Frame 30836-953), and Assignment of rights
`
`from Jazz to Jazz Ireland (Reel/Frame 33480-220). The Assignments were
`
`recorded with the United States Patent and Trademark Office on July 9, 2013 and
`
`July 29, 2014. Jazz is currently the exclusive licensee of the ’306 patent.
`
`RELATED MATTERS
`
`Pursuant to 37 C.F.R. § 42.8(b)(2), the undersigned state that the ’306 patent
`
`is the subject of four, currently-pending litigations: Jazz Pharmaceuticals, Inc. et
`
`al. v. Amneal Pharmaceuticals LLC et al., 2:13-cv-391 (consolidated) (D.N.J.);
`
`Jazz Pharmaceuticals, Inc. et al. v. Roxane Laboratories, Inc., 2:15-cv-1360
`
`03387-00001/7349405.1
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case IPR2016-00024
` Patent 8,772,306
`
`
`Patent Owner Mandatory Notices
`
`
`(D.N.J.); Jazz Pharmaceuticals, Inc. et al. v. Wockhardt Bio AG et al., 2:15-cv-
`
`5619 (D.N.J.); and Jazz Pharmaceuticals, Inc. et al. v. Lupin Ltd. et al., 2:15-cv-
`
`6548 (D.N.J.). Two other cases, Jazz Pharmaceuticals, Inc. et al. v. Amneal
`
`Pharmaceuticals, LLC, 2:15-cv-6562 (D.N.J.) and Jazz Pharmaceuticals, Inc. et al.
`
`v. Par Pharmaceutical, Inc., 2:15-cv-7580 (D.N.J.), concern a patent related to the
`
`’306 patent.
`
`The ’306 patent is also the subject of a petition for inter partes review filed
`
`by Par Pharmaceutical, Inc. (IPR2016-00002).
`
`Further, PCT/US14/19217, filed on February 28, 2014, claims the benefit of
`
`the ’306 patent.
`
`LEAD COUNSEL AND BACK-UP COUNSEL (37 C.F.R. § 42.8(b)(3))
`
`Lead Counsel:
`
`
`
`F. Dominic Cerrito (Reg. No. 38,100)
`
`Contact Information:
`
`Quinn Emanuel Urquhart & Sullivan, LLP
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`51 Madison Avenue, 22nd Floor
`
`New York, NY 10010
`
`Email: nickcerrito@quinnemanuel.com
`
`Telephone: 212-849-7000
`
`Back-Up Counsel:
`
`John V. Biernacki (Reg. No. 40,511)
`
`Contact Information:
`
`Jones Day
`
`03387-00001/7349405.1
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case IPR2016-00024
` Patent 8,772,306
`
`
`Patent Owner Mandatory Notices
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`North Point
`
`901 Lakeside Avenue
`
`Cleveland, OH 44114
`
`Email: jvbiernacki@jonesday.com
`
`Telephone: 216-586-3939
`
`Back-Up Counsel:
`
`Evangeline Shih (Reg. No. 50,170)
`
`Contact Information:
`
`Quinn Emanuel Urquhart & Sullivan, LLP
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`51 Madison Avenue, 22nd Floor
`
`New York, NY 10010
`
`Email: evangelineshih@quinnemanuel.com
`
`Telephone: 212-849-7000
`
`Back-Up Counsel:
`
`Frank C. Calvosa (Reg. No. 69,064)
`
`Contact Information:
`
`Quinn Emanuel Urquhart & Sullivan, LLP
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`51 Madison Avenue, 22nd Floor
`
`New York, NY 10010
`
`Email: frankcalvosa@quinnemanuel.com
`
`Telephone: 212-849-7000
`
`
`
`
`
`
`
`
`
`
`
`03387-00001/7349405.1
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case IPR2016-00024
` Patent 8,772,306
`
`
`Patent Owner Mandatory Notices
`
`
`
`
`
`
`SERVICE INFORMATION
`
`Pursuant to 37 C.F.R. § 42.8(b)(4), please direct all correspondence to lead
`
`and back-up counsel at the above addresses. Patent Owner consents to email
`
`service at the above-specified email addresses.
`
`Date: October 28, 2015
`
` Respectfully submitted,
`
`By: /F. Dominic Cerrito (Reg. No. 38,100)/
` F. Dominic Cerrito (Reg. No. 38,100)
` Evangeline Shih (Reg. No. 50,170)
` Frank C. Calvosa (Reg. No. 69,064)
`QUINN EMANUEL URQUHART &
`SULLIVAN LLP
`51 Madison Avenue, 22nd Floor
`New York, NY 10010
`Tel: (212) 849-7000
`Fax: (212) 849-7100
`nickcerrito@quinnemanuel.com
`evangelineshih@quinnemanuel.com
`frankcalvosa@quinnemanuel.com
`
`John V. Biernacki (Reg. No. 40,511)
`JONES DAY
`North Point
`901 Lakeside Avenue
`Cleveland, Ohio 44114
`Tel: (216) 586-3939
`Fax: (216) 579-0212
`jvbiernacki@jonesday.com
`
`Attorneys for Jazz Pharmaceuticals
`
`
`
`
`
`03387-00001/7349405.1
`
`
`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`________________
`
`RANBAXY INC.
`Petitioner,
`
`v.
`
`JAZZ PHARMACEUTICALS, INC. and
`JAZZ PHARMACEUTICAL IRELAND LTD.
`Patent Owner
`
`________________
`
`Case IPR2016-00024
`Patent 8,772,306
`________________
`
`CERTIFICATE OF SERVICE
`
`
`
`
`
`03387-00001/7349405.1
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. § 42.6(e), the undersigned hereby certify that
`
`PATENT OWNER MANDATORY NOTICES UNDER 35 U.S.C. §§ 311-319
`
`AND 37 C.F.R. §§ 42.8, 42.100 ET. SEQ. and the attached POWER OF
`
`ATTORNEY and 3.73(b) STATEMENT were served on October 28, 2015 by
`
`filing these documents through the Patent Review Processing System, as well as e-
`
`mailing copies to Joseph.Reisman@knobbe.com, Carol.PitzelCruz@knobbe.com,
`
`Kerry.Taylor@knobbe.com, and BoxRanbaxy332@knobbe.com.
`
`Date: October 28, 2015
`
`03387-00001/7349405.1
`
` Respectfully submitted,
`
`By: /F. Dominic Cerrito (Reg. No. 38,100)/
` F. Dominic Cerrito (Reg. No. 38,100)
` Evangeline Shih (Reg. No. 50,170)
` Frank C. Calvosa (Reg. No. 69,064)
`QUINN EMANUEL URQUHART &
`SULLIVAN LLP
`51 Madison Avenue, 22nd Floor
`New York, NY 10010
`Tel: (212) 849-7000
`Fax: (212) 849-7100
`nickcerrito@quinnemanuel.com
`evangelineshih@quinnemanuel.com
`frankcalvosa@quinnemanuel.com
`
`John V. Biernacki (Reg. No. 40,511)
`JONES DAY
`North Point
`901 Lakeside Avenue
`Cleveland, Ohio 44114
`Tel: (216) 586-3939
`Fax: (216) 579-0212
`jvbiernacki@jonesday.com
`
`
`
`
`
`
`Attorneys for Jazz Pharmaceuticals
`
`
`
`03387-00001/7349405.1